Aileron Therapeutics Inc. (ALRN) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Aileron Therapeutics Inc. (ALRN)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

2.11

0.18 (9.33%)

At close: Jan 10, 2025, 9:00 PM

0.00

-100.00%

After-hours Dec 31, 1969, 07:00 PM EST

undefined% (undefined)

Bid	n/a
Market Cap	45.72M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-2.88
PE Ratio (ttm)	-0.73
Forward PE	n/a
Analyst	Strong Buy

Ask	n/a
Volume	63,394
Avg. Volume (20D)	100,186
Open	1.97
Previous Close	1.93
Day's Range	1.96 - 2.17
52-Week Range	1.61 - 7.42
Beta	undefined

About ALRN

Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,...

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date Jun 29, 2017

Employees 15

Stock Exchange NASDAQ

Ticker Symbol ALRN

Website https://www.aileronrx.com

Analyst Forecast

According to 1 analyst ratings, the average rating for ALRN stock is "Strong Buy." The 12-month stock price forecast is $19, which is an increase of 800.47% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Why Price Moved

2 months ago · Source

-13.29%

Aileron Therapeutics shares are trading lower. The... Unlock content with Pro Subscription

5 months ago · Source

-10.81%

Aileron Therapeutics shares are trading lower after the company reported worse-than-expected Q2 EPS results.

News

8 months ago · zacks.com

Down -36.29% in 4 Weeks, Here's Why Aileron Therapeutics (ALRN) Looks Ripe for a Turnaround

The heavy selling pressure might have exhausted for Aileron Therapeutics (ALRN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Stree...

1 year ago · zacks.com

Bears are Losing Control Over Aileron Therapeutics, Inc. (ALRN), Here's Why It's a 'Buy' Now

After losing some value lately, a hammer chart pattern has been formed for Aileron Therapeutics, Inc. (ALRN), indicating that the stock has found support. This, combined with an upward trend in earnin...

1 year ago · zacks.com

Aileron Therapeutics, Inc. (ALRN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Aileron Therapeutics, Inc. (ALRN) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agr...

2 years ago · zacks.com

What Makes Aileron Therapeutics, Inc. (ALRN) a New Buy Stock

Aileron Therapeutics, Inc. (ALRN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

2 years ago · zacks.com

Aileron Therapeutics, Inc. (ALRN) Moves to Buy: Rationale Behind the Upgrade

Aileron Therapeutics, Inc. (ALRN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

2 years ago · pennystocks.com

Penny Stocks to Buy on August 8th? 3 to Watch

Here's what you need to know about buying penny stocks on August 8th The post Penny Stocks to Buy on August 8th? 3 to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennySt...

2 years ago · pennystocks.com

How to Trade Penny Stocks in August 2022

What you need to know about trading penny stocks in August The post How to Trade Penny Stocks in August 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

2 years ago · investorplace.com

3 Oversold Biotech Stocks to Buy Now

Looking for oversold biotech stocks? These three have all seen significant drops this year despite promising catalysts for the future.

2 years ago · zacks.com

Is Aileron Therapeutics (ALRN) Outperforming Other Medical Stocks This Year?

Here is how Aileron Therapeutics, Inc. (ALRN) and Paragon 28, Inc. (FNA) have performed compared to their sector so far this year.

2 years ago · zacks.com

Is Aileron Therapeutics, Inc. (ALRN) Stock Outpacing Its Medical Peers This Year?

Here is how Aileron Therapeutics, Inc. (ALRN) and Becton Dickinson (BDX) have performed compared to their sector so far this year.

3 years ago · benzinga.com

Aileron Stock Is Trading Lower After Data Presentation For Chemoprotective Agent

Aileron Therapeutics Inc (NASDAQ: ALRN) presented new clinical data at the European Society of Medical Oncology ( ESMO21 ) Virtual Congress 2021 for ALRN-6924, a chemoprotective agent. Aileron is dev...

3 years ago · benzinga.com

Aileron Launches Early-Stage Study For Chemoprotective Candidate In Lung Cancer Settings

Aileron Therapeutics Inc (NASDAQ: ALRN) has initiated Phase 1b trial of ALRN-6924 as a chemoprotective agent to treat patients with non-small cell lung cancer undergoing chemotherapy. Aileron plans t...

3 years ago · seekingalpha.com

Aileron Therapeutics: Solving Chemotherapy's Toxicity

Chemotherapy is built into the treatment regime of nearly every cancer. However, chemotherapy's well-known toxicity can lead to patient discontinuation and poor quality-of-life.

3 years ago · seekingalpha.com

Aileron Therapeutics: Low Cash Balance, Early Stage, But Scientific Premise Is Interesting

Aileron Therapeutics has a long history of not doing much. Its data is early stage, but the scientific theory is interesting.

3 years ago · investorplace.com

7 Penny Stocks That Actually Have Buy Ratings

Many penny stocks are destined to fail, but these seven penny stocks may succeed. Wall Street has buy recommedations on them.

4 years ago · investorplace.com

ALRN Stock: What Investors Should Know About Aileron Therapeutics

As with many biopharma names, there's volatility and risk in ALRN stock. This firm is seeking to reduce the effects of chemotherapy.